📰 Primary Outcomes News
Primary Outcomes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Outcomes. Real-time updates on events, politics, business and more.
November 13, 2023
Investigators believe targeted immunomodulation with SEL-212 may have the potential to introduce a new uricase-based therapy for patients with gout refractory to conventional treatment.
October 20, 2023
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
February 25, 2022
/PRNewswire/ -- The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to...
February 25, 2022
/PRNewswire/ -- The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to...